Skip to main navigation Skip to search Skip to main content

Human genetic and immunological determinants of critical COVID-19 pneumonia

  • COVID Human Genetic Effort
  • Rockefeller University
  • Université Paris Cité
  • Cemil Taşcıoglu City Hospital
  • Al Jalila Children's Hospital
  • Vita-Salute San Raffaele University
  • Hospices civils de Lyon
  • Helix OpCo LLC
  • Lille University Hospital
  • Center for Infection and Immunity of Lille (CIIL)
  • Shupyk National Healthcare University of Ukraine
  • Utrecht University
  • Sidra Medical and Research Center
  • Universidad de Antioquia
  • August Pi i Sunyer Biomedical Research Institute
  • Charles University
  • Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
  • Université catholique de Louvain
  • IRCCS Ospedale pediatrico Bambino Gesù - Roma
  • Yildirim Beyazit Universitesi
  • Bellvitge Biomedical Research Institute
  • ICREA
  • Instituto de Salud Carlos III
  • Ankara City Hospital
  • University of Wisconsin-Madison
  • Hospital Universitario Nuestra Senora de Candelaria
  • CIBER Enfermedades Respiratorias
  • Institute of Technology and Renewable Energies
  • Hospital de Gran Canaria Dr. Negrin
  • University Fernando Pessoa Canarias
  • Faculdades Pequeno Príncipe
  • University of British Columbia
  • Sorbonne Université
  • Uniformed Services University of the Health Sciences
  • Trinity College Dublin
  • Hospital Universitari Mútua Terrassa
  • Fundació Docència i Recerca Mutua Terrassa
  • University of Barcelona
  • Tehran University of Medical Sciences
  • Amsterdam UMC
  • McGill University
  • Fundacion Rioja Salud
  • University of Colorado Anschutz Medical Campus
  • Ondokuz Mayis University
  • University of Health Sciences
  • University of Brescia
  • Academy of Athens

Research output: Contribution to journal › Review article › peer-review

319 Scopus citations

Abstract

SARS-CoV-2 infection is benign in most individuals but, in around 10% of cases, it triggers hypoxaemic COVID-19 pneumonia, which leads to critical illness in around 3% of cases. The ensuing risk of death (approximately 1% across age and gender) doubles every five years from childhood onwards and is around 1.5 times greater in men than in women. Here we review the molecular and cellular determinants of critical COVID-19 pneumonia. Inborn errors of type I interferons (IFNs), including autosomal TLR3 and X-chromosome-linked TLR7 deficiencies, are found in around 1–5% of patients with critical pneumonia under 60 years old, and a lower proportion in older patients. Pre-existing auto-antibodies neutralizing IFNα, IFNβ and/or IFNω, which are more common in men than in women, are found in approximately 15–20% of patients with critical pneumonia over 70 years old, and a lower proportion in younger patients. Thus, at least 15% of cases of critical COVID-19 pneumonia can be explained. The TLR3- and TLR7-dependent production of type I IFNs by respiratory epithelial cells and plasmacytoid dendritic cells, respectively, is essential for host defence against SARS-CoV-2. In ways that can depend on age and sex, insufficient type I IFN immunity in the respiratory tract during the first few days of infection may account for the spread of the virus, leading to pulmonary and systemic inflammation.

Original languageEnglish
Pages (from-to)587-598
Number of pages12
JournalNature
Volume603
Issue number7902
DOIs
StatePublished - 24 Mar 2022

Fingerprint

Dive into the research topics of 'Human genetic and immunological determinants of critical COVID-19 pneumonia'. Together they form a unique fingerprint.

Cite this